Thursday, May 26, 2022 8:08:55 PM
New York Yankees and Duke Basketball
Recent PMVP News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 12:00:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:00:14 PM
- PMV Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Highlights • GlobeNewswire Inc. • 05/09/2024 12:00:00 PM
- PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors • GlobeNewswire Inc. • 03/27/2024 12:00:00 PM
- PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women’s Cancer • GlobeNewswire Inc. • 03/18/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:05:19 PM
- PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights • GlobeNewswire Inc. • 02/29/2024 09:01:00 PM
- PMV Pharmaceuticals to Participate in the TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/26/2024 01:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/24/2024 02:01:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/22/2024 09:06:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/22/2024 09:04:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:02:53 PM
- PMV Pharmaceuticals Announces Prioritization of PC14586 Clinical Development and Extended Cash Runway • GlobeNewswire Inc. • 01/18/2024 09:01:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 09:18:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:01:59 PM
- PMV Pharmaceuticals Strengthens Leadership with Key Appointments as Company Advances into Late-Stage Development • GlobeNewswire Inc. • 01/05/2024 09:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 01:00:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 01:00:42 PM
- PMV Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Highlights • GlobeNewswire Inc. • 11/09/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 09:02:32 PM
- PMV Pharmaceuticals Updated PC14586 Phase 1 Data Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a TP53 Y220C Mutation • GlobeNewswire Inc. • 10/12/2023 04:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 08:02:52 PM
- PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics and Host a KOL Webinar • GlobeNewswire Inc. • 10/11/2023 04:00:00 PM
- PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics • GlobeNewswire Inc. • 09/20/2023 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2023 08:26:37 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM